We conducted a systematic review and network meta-analysis (NMA) of RCTs to compare the efficacy in achieving target Hb levels and acceptability of different HIF-PHIs and ESAs for treating anemia in CKD patients undergoing dialysis. Here, GSTM1 is linked to anemia.